Assessing the costs and benefits of an oral vaccine for raccoon rabies: a possible model.
Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs.
Meltzer
M I
MI
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
D000284:Administration, Oral; D000818:Animals; D000835:Animals, Wild / Q000276:immunology / Q000821:virology; D017046:Cost Savings / Q000191:economics; D003362:Cost-Benefit Analysis; D018803:Models, Economic; D011818:Rabies / Q000191:economics / Q000517:prevention & control* / Q000662:veterinary*; D011819:Rabies Vaccines / Q000191:economics* / Q000276:immunology*; D011821:Raccoons / Q000276:immunology / Q000821:virology*; D014612:Vaccines
D011819:Rabies Vaccines; D014612:Vaccines